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Normally, Rho GTPases are activated by the removal
of bound GDP and the concomitant loading of GTP
catalyzed by members of the Dbl family of guanine
nucleotide exchange factors (GEFs). This family of
GEFs invariantly contain a Dbl homology (DH) domain
adjacent to a pleckstrin homology (PH) domain, and
while the DH domain usually is sufficient to catalyze
nucleotide exchange, possible roles for the conserved
PH domain remain ambiguous. Here we demonstrate
that the conserved PH domains of three distinct Dbl
family proteins, intersectin, Dbs, and Tiam1, selec-
tively bind lipid vesicles only when phosphoinositides
are present. While the PH domains of intersectin and
Dbs promiscuously bind several multiphosphorylated
phosphoinositides, Tiam1 selectively interacts with
phosphatidylinositol 3-phosphate (KD 5–10 M). In ad-
dition, and in contrast to recent reports, catalysis of
nucleotide exchange on nonprenylated Rac1 provided
by various extended portions of Tiam1 is not influ-
enced by (a) soluble phosphoinositide head groups, (b)
dibutyl versions of phosphoinositides, or (c) lipid ves-
icles containing phosphoinositides. Likewise, GEF ac-
tivity afforded by DH/PH fragments of intersectin and
Dbs are also not altered by phosphoinositide interac-
tions. These results strongly suggest that unless all
relevant components are localized to a lipid membrane
surface, Dbl family GEFs generally are not intrinsi-
cally modulated by binding phosphoinositides.
Rho GTPases cycle between inactive and active states based
upon conformational alterations imposed by the state of bound
guanine nucleotide. Rho GTPases bound to GDP are inactive in
downstream signaling, while GTP-bound versions modulate a
plethora of downstream effectors typically associated with mor-
phological alterations of the cytoskeleton and activation of
stress response genes (1–5). Consistent with their central role
in regulating cellular differentiation and proliferation, consti-
tutively active Rho GTPases are sufficient to promote cellular
transformation. Similarly, Ras-induced transformation is de-
pendent on Rac1, a Rho GTPase (6–9). Since the proper control
of a multitude of signaling cascades by G proteins depends
critically upon the state of bound nucleotide, G proteins have
evolved several, tightly controlled processes for regulating the
binding and hydrolysis of guanine nucleotides. For Rho GT-
Pases, the exchange of bound GDP for GTP is catalyzed by a
large class of guanine nucleotide exchange factors (GEFs)1
related to the gene product for Dbl (diffuse B-cell lymphoma)
(10). Similarly to constitutively active forms of Rho GTPases,
the unregulated activation of Dbl family members is generally
associated with cellular transformation, and many Dbl family
members are proto-oncogenic (7, 11).
Dbl family proteins invariantly contain an 300-amino acid
span composed of a Dbl homology (DH) domain in tandem with
a pleckstrin homology (PH) domain (12, 13). DH domains are
sufficient to catalyze nucleotide exchange; however, exchange
activity is often enhanced by inclusion of the adjacent PH
domain (14). While DH domains serve as the major docking site
for Rho GTPases, roles for the adjacent, conserved PH domains
remain unclear. The invariant DH/PH domain architecture in
all Dbl family members strongly suggests that associated PH
domains have a unique and highly conserved role in regulating
nucleotide exchange. Simple structural stabilization of the DH
domain by the adjacent PH domain as suggested by the Tiam1-
DH/PHRac1 crystal structure (15) is an unsatisfactory expla-
nation for the universal pairing of DH and PH domains. A
multitude of other domains could easily be imagined to serve
this purpose.
In many other proteins, PH domains bind phosphoinositides
to function as regulated tethers to cellular membranes (16–20).
Although PH domains typically share very low sequence iden-
tity, all possess a common -sandwich fold capped at one end
with a C-terminal helix. Numerous studies indicate that PH
domains generally bind phosphoinositides with a wide degree
of affinity and specificity via clusters of basic residues located
within the highly variable loops between strands 1/2 and
3/4 (21–23). Several reports present conflicting data describ-
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ing how phosphoinositide binding to DH-associated PH do-
mains modulates GEF activity on Rho GTPases (24–28). Spe-
cifically, for Tiam1 acting on Rac1, one report (28) identifies
phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) as an ob-
ligate activator of nucleotide exchange activity, while another
report (27) describes the identical phosphoinositide as inhibi-
tory to exchange and phosphatidylinositol 3,4,5-trisphosphate
(PtdIns(3,4,5)P3) and phosphatidylinositol 3,4-bisphosphate
(PtdIns(3,4)P2) as activators of GEF activity.
To define potential functions underpinning the invariant
conservation of DH domains with PH domains, we have used
several techniques to measure interactions between phospho-
inositides and the DH/PH fragments of Tiam1, Dbs (Dbl’s big
sister), and intersectin. Here we demonstrate that phospho-
inositide binding localizes to the PH domains with no appre-
ciable binding attributable to the DH domains. Also, the PH
domains possess measurable affinities only for lipid vesicles
containing phosphoinositides. While the DH/PH fragments of
intersectin and Dbs bind various phosphoinositides, Tiam1
preferentially binds phosphatidylinositol 3-phosphate (PtdIns
(3)P) with low micromolar affinity. Among PH domains, pref-
erential binding of PtdIns(3)P is rare and may implicate Tiam1
in events that occur on the surface of endosomal components
where PtdIns(3)P is localized. In addition, and in contrast with
previous studies (24–28), we find no evidence that phospho-
inositides modulate the ability of Dbl family proteins to cata-
lyze in vitro nucleotide exchange within soluble Rho family
GTPases.
EXPERIMENTAL PROCEDURES
Protein Production—The coding regions for each construct (human
intersectin-DH-(1229–1445), intersectin-DH/PH-(1229–1580), murine
Dbs-DH-(623–831), Dbs-DH/PH-(623–967), and human Tiam1-DH/PH-
(1033–1401)) were expressed in Escherichia coli strain BL21(DE3) and
purified to homogeneity as previously described (7, 15).2 The coding
region for Tiam1-PSD-95/Dlg/ZO1/DH/PH (residues 858–1406) was
amplified by polymerase chain reaction, subcloned into pPROEX HTA
(Life Technologies, Inc.), and overexpressed as a hexahistidine fusion in
E. coli strain BL21(DE3). Cells were lysed by French press and clarified
by ultracentrifugation, and the supernatant was loaded onto a nickel-
chelating Sepharose column (Amersham Pharmacia Biotech) followed
by elution with an imidazole gradient. Fractions rich in Tiam1-PDZ/
DH/PH were pooled and loaded onto an S-200 gel filtration column to
isolate highly purified Tiam1-PDZ/DH/PH. An insect cell expression
vector harboring the coding region of the last 1199 residues of Tiam1
fused to a KT3 epitope of SV40 large T antigen was kindly supplied by
Onyx Pharmaceuticals and expressed in 1 liter of High Five insect cells
(Invitrogen) for 48 h at 27 °C. The cells containing the overexpressed
Tiam1 fragment (hereafter called Tiam1-PH/PDZ/DH/PH) were har-
vested, lysed by sonication, and clarified by ultracentrifugation. Visu-
alization by Coomassie Blue staining and Western blotting with mono-
clonal antibody directed against the KT3 tag (Babco) verified the
presence of Tiam1-PH/PDZ/DH/PH in the soluble fraction of the lysate.
This supernatant was subsequently applied to a HiTrap SP ion ex-
change column (Amersham Pharmacia Biotech) followed by elution
with a linear salt gradient. Fractions rich in Tiam1-PH/PDZ/DH/PH
were pooled and concentrated for analysis. For dot-blot screens, DH/PH
proteins were expressed as GST fusions (see below). Human Rac1
(residues 1–188, C188S) and Cdc42 (residues 1–188, C188S) were ex-
pressed and purified bound to GDP as previously described (15). Protein
concentrations were determined by A280 using calculated extinction
coefficients.
Dot-Blot Screens—Dot-blot assays were performed exactly as de-
scribed (23). Briefly, DH/PH fragments were amplified by polymerase
chain reaction and subcloned into pGEX-2TK. Expressed and purified
DH/PH proteins fused to GST were radiolabeled with 32P using protein
kinase A and were applied to nitrocellulose filters containing various
phosphoinositides prior to extensive washing and visualization of
bound radioactivity using a PhosphorImager (Molecular Dynamics,
Inc., Sunnyvale, CA). One-microliter spots of phospholipids (at 2 mg/ml)
were placed on the nitrocellulose in the pattern shown in Fig. 1.
Vesicle Preparation—Phospholipids were purchased from Matreya,
Inc. Small unilamellar vesicles (SUVs) were prepared by bath sonica-
tion of a dispersion of lipids into aqueous 20 mM Hepes (pH 7.5) and 150
mM NaCl. SUVs contained (by molar fraction) 80% dipalmitoyl phos-
phatidylcholine, 17% dipalmitoyl phosphatidylserine, 3% of a phos-
phohyinositide (PtdIns(3)P, PtdIns(3,4)P2, PtdIns(4,5)P2, or PtdIns
(3,4,5)P3), and 0.1% N-biotinylated dipalmitoyl phosphatidylethano-
lamine when indicated.
Surface Plasmon Resonance—SUV binding was monitored by surface
plasmon resonance using a BIAcore 2000 instrument. A streptavidin
(SA5) chip (BIAcore) was mounted in the instrument, and SUV surfaces
were created in each flow cell by capturing the SUVs via biotin-strepta-
vidin interactions. An empty flow cell was maintained to control for
nonspecific binding to the carboxymethylated dextran chip. Equal
amounts of SUV were immobilized on each respective flow cell as judged
by increases in response units displayed on the sensorgrams. Typically,
SUVs were loaded onto flow cell surfaces until 2000 response units were
achieved. The surfaces were stable and did not decay significantly
throughout the titrations.
Experiments were performed at 25 °C with 100 l/min as the flow
rate. Proteins were dialyzed against 20 mM Hepes (pH 7.5) and 150 mM
NaCl, filtered by centrifugation, and degassed. Each surface of the
biosensor was then exposed to 25-l injections of protein solution (as-
sociation phase) followed by 100 l of buffer (dissociation phase) via the
kinject command. Between injections, a 5-l pulse of 1 M NaCl and 50
mM NaOH regenerated the SUV surfaces. Each GEF was injected at
concentrations ranging from 0 to 50 M.
Raw sensorgrams from each titration were aligned, and the signal
due to binding the empty flow cell was subtracted from each curve. The
data were then globally fit to a 1:1 Langmuir binding isotherm using
BIAevaluation 3.0 software (29). The resulting dissociation constants
(KD) were obtained from the average of several experiments. Represent-
ative titrations are plotted as the steady state binding response (Req)
over the range of GEF concentrations.
Isothermal Titration Calorimetry—Inositol phosphates were pur-
2 W. Pruitt, M. Baumeister, K, Rossman, M. Lemmon, J. Sondek, B.
Kay, and C. Der, submitted for publication.
FIG. 1. Analysis of GEF phospho-
inositide binding specificity using a
dot-blot screen. Radiolabeled GST-
DH/PH fusion proteins were applied to
nitrocellulose filters containing various
phosphoinositides. After washing, the
bound protein was visualized using a
PhosphorImager as described under “Ex-
perimental Procedures.”
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chased from Echelon or Calbiochem. Each D-myo-inositol phosphate
ligand (inositol 1,3-bisphosphate (Ins(1,3)P2), D-myo-inositol 1,3,4-
trisphosphate, D-myo-inositol 1,3,5-trisphosphate, D-myo-inositol 1,4,5-
trisphosphate, D-myo-inositol 1,3,4,5-tetrakisphosphate, and D-myo-ino-
sitol 1,2,3,4,5,6-hexakisphosphate) was dissolved in isothermal
titration calorimetry (ITC) buffer (20 mM phosphate, pH 7.5, 150 mM
NaCl), and their concentrations were based on the amount stated by the
supplier. Protein solutions were dialyzed exhaustively against ITC
buffer, filtered, and degassed before each injection. Titrations were
performed at 20 °C using an Omega MCS calorimeter (MicroCal, Inc.).
Twenty 15-l injections or 30 10-l injections of each inositol phosphate
(260–360 M) were titrated into a GEF solution (26–36 M) in the
calorimeter cell (1.39 ml). Data were analyzed by integrating the peaks
with Origin 5.0 software. Heats of dilution were subtracted from heats
of binding, and the data were fit to a one-binding site model (30).
Nucleotide Exchange Assay—Guanine nucleotide exchange assays
were performed as previously described in 2-ml reactions (15). Briefly,
FIG. 2. Binding of intersectin-DH/PH protein to phospho-
inositide-containing vesicles by surface plasmon resonance.
GEF binding to phosphoinositides was analyzed using SPR in a BIAcore
2000. Intersectin-DH and intersectin-DH/PH solutions (50 M) were
injected over immobilized SUV surfaces (3% of indicated phosphoinosi-
tide, 17% dipalmitoyl phosphatidylserine, 80% dipalmitoyl phosphati-
dylcholine, 0.1% N-biotinylated dipalmitoyl phosphatidylethanolamine
by molar fraction) for 15 s (association phase), and then flow was
switched to buffer alone (dissociation phase). Binding was monitored by
an increase in response units (RU) as a function of time. Raw data were
normalized to the signal achieved from nonspecific binding to an empty
flow cell surface.
FIG. 3. Differential specificity of intersectin, Dbs, and Tiam1
DH/PH fragments for phosphoinositide-containing SUVs. GEF
solutions (0, 0.8, 1.5, 3.1, 6.2, 12.5, 25, and 50 M) were injected over
various SUV sensor surfaces in the same manner as depicted in Fig. 2.
The sensorgrams were aligned and globally fit to a 1:1 binding model
using BIAevaluation software as described under “Experimental Pro-
cedures.” The resulting binding curves are presented as the steady state
binding response (Req) as a function of GEF concentration. Estimated
KD values from the best fit curves are presented in Table I.
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nucleotide exchange was monitored as the increase in relative fluores-
cence of the GTP analog mant-GTP upon binding G protein in a reaction
buffer containing 20 mM Tris (pH 7.5), 50 mM NaCl, 10 mM MgCl2, 1 mM
dithiothreitol, 50 g/ml bovine serum albumin, and 10% glycerol. Prior
to the addition of GEF, a 1 M concentration of the appropriate G
protein was incubated with 200 nM mant-GTP at 20 °C in a thermo-
statted cuvette, and fluorescence was measured using a PerkinElmer
Life Sciences LS-50B (ex  360 nm; em  440 nm; slits  5/5 nm) (31,
32). After equilibration, 10 nM GEF or buffer (uncatalyzed trace) was
added.
RESULTS
Dot-Blot Screens—In order to rapidly screen Dbl PH domains
for phosphoinositide affinity, we utilized an established dot-
blot assay (23). This qualitative method has been used to iden-
tify PH domain-phosphoinositide interactions, and results typ-
ically correlate well with other modes of binding analysis. The
DH/PH regions from intersectin, Dbs, and Tiam1 fused to GST
were expressed, purified, and radiolabeled with protein kinase
A as previously described (23). These 32P-labeled GST-DH/PH
proteins were next applied to nitrocellulose filters that were
spotted previously with various phosphoinositides (see “Exper-
imental Procedures”). As shown in Fig. 1, intersectin and Dbs
recognized several phosphoinositides, while Tiam1 specifically
interacted with only PtdIns(3)P of the panel of phosphoinosi-
tides screened. The GST protein alone did not display signifi-
cant signal for any lipid (data not shown). This differential
phosphoinositide selectivity observed for these GEFs using the
dot-blot assay prompted us to further evaluate these interac-
tions using more quantitative measurements.
Surface Plasmon Resonance—Given the ability of the DH/PH
fragments of Tiam1, Dbs, and intersectin to bind phosphoinosi-
tides on a dot-blot screen, we sought to assess these protein-lipid
interactions in a more physiological situation. SUVs composed of
3% molar fraction phosphoinositide were immobilized on a
streptavidin SA chip (BIAcore) in a BIAcore 2000 instrument via
biotinylated phosphatidylethanolamine (33). Solutions of highly
purified, untagged, catalytically active DH and DH/PH frag-
ments (see “Experimental Procedures”) were injected over SUV
surfaces followed by buffer to promote dissociation. Binding was
monitored in real time using surface plasmon resonance (SPR).
Fig. 2 displays representative sensorgrams of intersectin-DH and
intersectin-DH/PH applied to flow cells coated with PtdIns(3)P-,
PtdIns(4,5)P2-, and PtdIns(3,4,5)P3-containing vesicles respec-
tively. The DH domain of intersectin or that of Dbs (data not
shown) displayed no measurable affinity for any lipid surface
tested, while extended fragments of intersectin or Dbs containing
the tandem DH and PH domains possessed significant affinity for
SUVs doped with phosphoinositides. This differential binding
between DH and DH/PH domains implicates the PH domain of
FIG. 4. Titration calorimetry of inositol phosphates binding to intersectin-DH/PH and Tiam1-DH/PH. Various inositol phosphates
were titrated into solutions of intersectin-DH/PH (A) and Tiam1-DH/PH (B) in a calorimeter as described under “Experimental Procedures.” The
heat evolved per injection is displayed as a function of molar ratio (inositol phosphate/GEF). Curves of best fit are shown for titrations displaying
detectable binding. For intersectin-DH/PH (A), the dissociation constants from the D-myo-inositol 1,2,3,4,5,6-hexakisphosphate (Ins(1,2,3,4,5,6)P6)
and D-myo-inositol 1,3,4,5-tetrakisphosphate (Ins(1,3,4,5)P4) titrations displayed are 0.8 and 10 M, respectively. For Tiam1-DH/PH (B), the
estimated KD value for the Ins(1,3)P2 titration displayed is 5 M. Due to limitations in protein quantity, Dbs-DH/PH was not evaluated by
calorimetry.
TABLE I
SPR results for DH/PH fragments binding to phosphoinositide-
containing SUVs
KD values (M) were estimated from best fits to the SPR data pre-
sented in Fig. 3. Values reported with a greater than sign reflect lack of
saturable binding for the highest concentration of GEF (50 M) exam-
ined. Each dissociation constant is the mean of several experiments
with the errors cited as S.D.
SUV Intersectin-DH/PH Dbs-DH/PH Tiam1-DH/PH
3% PtdIns(3,4,5)P3  50  50  50
3% PtdIns(4,5)P2 4.2  2 11  6  50
3% PtdIns(3)P  50  50 10  7
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Dbl family GEFs in mediating phosphoinositide-dependent mem-
brane localization.
We measured GEF binding to SUVs over a range of DH/PH
concentrations to obtain quantitative binding constants. Disso-
ciation constants for each GEF-SUV binding curve were esti-
mated by globally fitting the sensorgrams to a 1:1 Langmuir
binding model, and resulting binding isotherms are presented
as the steady state binding signal as a function of GEF concen-
tration in Fig. 3. All GEFs displayed little affinity for vesicles
that lack phosphoinositides (80% dipalmitoyl phosphatidylcho-
line, 20% dipalmitoyl phosphatidylserine, and trace amounts of
N-biotinylated dipalmitoyl phosphatidylethanolamine (0.1%
molar fraction)). In contrast, intersectin-DH/PH and Dbs-
DH/PH bound with micromolar range KD values to vesicles
containing phosphoinositides, with higher affinity for
PtdIns(4,5)P2 relative to PtdIns(3,4,5)P3 and PtdIns(3)P.
Tiam1-DH/PH showed significant specificity for SUVs contain-
ing PtdIns(3)P, consistent with the dot-blot results, but did not
bind significantly to PtdIns(4,5)P2 or PtdIns(3,4,5)P3. The es-
timated dissociation constants for these titrations are summa-
rized in Table I and correlate very well with the pattern of
binding observed using the dot-blot assay.
Titration Calorimetry—To investigate the selectivity of these
PH domains for the head groups of phosphoinositides in solu-
tion, ITC was used to measure heats of binding upon titration
of individual inositol phosphates into solutions of GEFs (see
Fig. 4). The small amount of heat released during the titrations
strongly limits our ability to discern specificities between PH
domains and phosphoinositides. However, consistent with the
other methods of analysis, Tiam1-DH/PH displayed the great-
est affinity for Ins(1,3)P2, the head group of PtdIns(3)P, and
consistently bound with an approximate KD of 5 M, which is
similar to the KD of 10 M measured by SPR for the interaction
of Tiam1-DH/PH and SUVs doped with PtdIns(3)P. The only
other inositol phosphate releasing any measurable amount of
heat upon binding Tiam1-DH/PH was Ins(1,3,4)P3. Intersectin-
DH/PH exhibited increasing affinity for inositol phosphates
with an increasing number of phosphate groups (negative char-
ge). This trend for intersectin argues that, at least in bulk
solution, in the absence of negative phospholipid membranes,
intersectin favors phosphoinositide head groups possessing a
large degree of localized negative charge, with little
stereospecificity.
Nucleotide Exchange Assay—The combination of our detec-
tion of selective phosphoinositide affinity by DH-associated PH
domains, coupled with previous reports of phosphoinositide-
induced modulation of GEF catalysis in solution, prompted us
to evaluate the effects of phosphoinositides on guanine nucle-
otide exchange catalyzed by the DH/PH portions of intersectin,
Dbs, and Tiam1 (see Fig. 5) (34). Consistent with previous work
(14, 15),2 the DH/PH portions of all three Dbl family GEFs
efficiently catalyze the exchange of bound GDP for GTP within
the appropriate G protein substrates as compared with reac-
tions lacking GEF (uncatalyzed reactions). However, the addi-
tion of 333 M SUVs containing 3% PtdIns(4,5)P2, 10 M
PtdIns(4,5)P2, water-soluble 10 M dibutyl-PtdIns(4,5)P2, or 10
M Ins(1,4,5)P3, the corresponding soluble head group, did not
FIG. 5. Effect of phosphoinositides on DH/PH-catalyzed nucle-
otide exchange on Cdc42 and Rac1. Guanine nucleotide exchange of
GDP was monitored in vitro by fluorescence of mant-GTP as described
under “Experimental Procedures.” One micromolar of the appropriate G
protein substrate (for intersectin-Cdc42 (A), for Dbs-Cdc42 (B), and for
Tiam1-Rac1 (C)) was incubated with lipid additives prior to the addition
of 10 nM GEF-DH/PH or buffer for the uncatalyzed trace (f). For
intersectin-DH/PH (A) and Dbs-DH/PH (B), reactions contained 10 M
D-myo-inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) (),10 M dibutyl-
PtdIns(4,5)P2 (), 333 M 3% PtdIns(4,5)P2 SUVs (E), no lipids ( ), 22
l of 1:1 CHCl3/CH3OH solvent (), or 10 M PtdIns(4,5)P2 in 22 l of
1:1 CHCl3/CH3OH solvent (‚). For Tiam1-DH/PH (C), reactions con-
tained similar additives with the exception of 10 M Ins(1,3)P2 (E),10
M dibutyl-PtdIns(3)P (), 333 M of 3% PtdIns(3)P SUVs (E), and 10
M PtdIns(3)P in 20 l of 1:1 CHCl3/CH3OH solvent (‚).
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significantly affect catalysis by intersectin-DH/PH (Fig. 5A) on
Cdc42. Similar results were obtained using SUVs containing
3% PtdIns(3,4,5)P3, (data not shown). In contrast, the addition
of 10 M PtdIns(4,5)P2 dramatically decreased the rate of Dbs-
catalyzed nucleotide exchange on Cdc42 (Fig. 5B). However,
this inhibition was also observed upon the addition of equiva-
lent amounts of the neat organic solvent required to solubilize
PtdIns(4,5)P2 in the absence of SUVs. In a similar fashion,
SUVs with added PtdIns(3)P, 10 M dibutyl-PtdIns(3)P, or 10
M Ins(1,3)P2 had no effect on nucleotide exchange catalyzed by
Tiam1-DH/PH operating on Rac1. Therefore, under various
conditions, phosphoinositides fail to alter guanine nucleotide
exchange within nonprenylated forms of Rac1 or Cdc42 cata-
lyzed by three distinct Dbl family GEFs.
Like most Dbl family GEFs, Tiam1 contains multiple do-
mains aside from the signature DH/PH region that may influ-
ence exchange activity (Fig. 6A). Consequently, two larger frag-
ments of Tiam1 were analyzed for exchange activity potentially
regulated by phosphoinositides. A 73-kDa segment of Tiam1
spanning the PDZ domain through the DH/PH region catalyzes
guanine nucleotide exchange within Rac1 similar to the
smaller DH/PH fragment (Fig. 6B). Furthermore, similar to our
previous observations, the exchange activity of Tiam1-PDZ/
DH/PH is not modulated by phosphoinositides under a variety
of conditions (Fig. 6B). Similarly, a 135-kDa fragment of Tiam1
produced in baculovirus and spanning the C-terminal PH do-
main through the N-terminal PH domain (28) also efficiently
catalyzes nucleotide exchange within Rac1 but not Cdc42 that
cannot be altered by the additions of various phosphoinositides
(Fig. 6C and data not shown). The catalyzed exchange cannot
be attributed to exogenous lipids or other contaminants, since
soluble lysate derived from uninfected Sf9 cells imparts no
exchange activity to Rac1 above spontaneous rates (Fig. 6C).
Apparently in solution, the minimal DH/PH fragment of Tiam1
accurately recapitulates the exchange activity of extended por-
tions of Tiam1, and potential in vitro regulation of exchange
activity by phosphoinositides is not imparted by other domains
of Tiam1 or the original source of heterologous expression.
DISCUSSION
The strict conservation of PH domains adjacent to DH do-
mains in Dbl family members strongly suggests that these PH
domains share a highly conserved function essential to the
intrinsic mechanism of guanine nucleotide exchange catalyzed
by Dbl family proteins. In order to elucidate potential functions
for these PH domains, the DH/PH portions of intersectin, Dbs,
and Tiam1 were functionally characterized for selectivity and
affinity toward a series of phosphoinositides under a variety of
experimental conditions. PH domains generally bind phospho-
inositides, and consistent with this observation, the DH/PH
fragments of intersectin, Dbs, and Tiam1 preferentially bound
phosphoinositides relative to other anionic membrane lipids
(i.e. dipalmitoyl phosphatidylserine). The DH/PH fragment of
Dbs promiscuously binds phosphoinositides, showing little se-
lectivity between various phosphoinositides blotted on nitrocel-
lulose membranes. The intersectin DH/PH portion appears a
little more selective, preferring PtdIns(4,5)P2. When phospho-
inositides are presented within a background of anionic SUVs
and affinities are measured by SPR, the DH/PH fragments of
both Dbs and intersectin bind PtdIns(4,5)P2, with KD values of
11 and 4 M, respectively, and both were able to discriminate
PtdIns(4,5)P2 from PtdIns(3,4,5)P3 and PtdIns(3)P. These re-
sults emphasize the importance of accounting for the physical
format used to present phosphoinositides to PH domains.
FIG. 6. Effect of phosphoinositides
on Tiam1-catalyzed nucleotide ex-
change on Rac1. Full-length sequences
of Tiam1, Stef, and Still-life were aligned
using ClustalX and analyzed for regions
of high similarity using Plotsimilarity in
GCG (53, 54). The domain organization of
Tiam1 is displayed under corresponding
regions of a similarity plot A, labeled do-
mains include a region predicted to form a
coiled-coil (coil) and a putative Ras bind-
ing domain (RBD). Guanine nucleotide
exchange assays were performed exactly
as described in the legend to Fig. 5. For
Tiam1-PDZ/DH/PH (B), and Tiam1-PH/
PDZ/DH/PH (C), reactions contained 333
M 3% PtdIns(3,4)P2 SUVs (), 333 M
3% PtdIns(4,5)P2 SUVs (E), 333 M 3%
PtdIns(3,4,5)P3 SUVs (‚), 10 M
PtdIns(3,4)P2 (), 10 M PtdIns(4,5)P2
(*), or 10 M PtdIns(3,4,5)P3 (inverted tri-
angle). A reaction containing the equiva-
lent amount of soluble lysate from unin-
duced cells in place of purified Tiam1 is
also displayed ().
Phosphoinositide Selectivities of Dbl PH Domains 45873
In contrast, using three highly complementary approaches,
Tiam1-DH/PH specifically recognized PtdIns(3)P but did not
bind significantly to either PtdIns(4,5)P2 or PtdIns(3,4,5)P3.
PtdIns(3)P is required for proper localization of regulators of
endocytic membrane fusion through specific interactions with
FYVE domains (35–40) and is not normally associated with PH
domain function. To date, very few PH domains have been
implicated in selectively binding PtdIns(3)P, and these past
studies have relied mainly on qualitative dot-blot analyses (41,
42). Unfortunately, the C-terminal PH domain of Tiam1 is
lacking traditionally defined consensus sequences normally as-
sociated with binding the 3-phosphate of inositol phosphates.
Also, within the Tiam1-DH/PHRac1 crystal structure, the
1/2 and 3/4 loops of the PH domain are unordered, making
it difficult to assign residues potentially involved in ligating
PtdIns(3)P. Aside from the DH-associated PH domain, Tiam1
contains a second N-terminal PH domain that has been re-
ported to interact specifically with PtdIns(3,4,5)P3, and both N-
and C-terminal PH domains have been implicated in recruiting
Tiam1 to the plasma membrane in vivo (43–45). Therefore,
Tiam1 may use its two PH domains to sense distinct pools of
intracellular phosphoinositides, resulting in pleiotropic re-
sponses at different cellular locations, depending on the levels
of PtdIns(3,4,5)P3 and PtdIns(3)P.
The low micromolar affinities of the PH domains of intersec-
tin and Dbs for PtdIns(4,5)P2, as well as Tiam1 for PtdIns(3)P,
are consistent with the dissociation constants commonly re-
ported for the majority of PH domains interacting with phos-
phoinositides (19, 46). These weak interactions appear to be
insufficient to drive directly the binding of proteins to mem-
branes, and it is thought that secondary sites of membrane
attachment are required to effectively localize proteins to mem-
brane surfaces (19). Consistent with this notion, the DH-asso-
ciated PH domains of Tiam1, Dbl, Vav, and Sos1 lack critical
structural determinants required for high affinity phospho-
inositide binding as highlighted by several crystal structures of
PH domains in complex with inositol phosphates (47, 48) and
complementary functional analyses (49). For Dbl family GEFs,
interactions between membrane-resident GTPases and DH do-
mains, coupled with interactions between specific phospho-
inositides and PH domains, mostly likely serves to enhance
membrane affinity of Dbl family proteins while simultaneously
ensuring the proper subcellular localization and fidelity of Dbl
family proteins for specific G proteins.
While we have quantitatively defined the specific phospho-
inositides that bind the DH-associated PH domains of intersec-
tin, Dbs, and Tiam1, we have been unable to observe any
allosteric regulation of exchange activity mediated by concen-
trations of phosphoinositides sufficient to occupy fully the PH
domains adjacent to DH domains. Recent reports (27, 28) pres-
ent conflicting data describing the in vitro regulation of Tiam1-
catalyzed exchange on nonprenylated Rac1 mediated by phos-
phoinositides. In one instance (27), both PtdIns(3,4,5)P3 and
PtdIns(3,4)P2 modestly enhanced (2-fold) guanine nucleotide
exchange mediated by Tiam1, while PtdIns(4,5)P2 reduced
GDP release, and phosphoinositide regulation was attributed
to the N-terminal PH domain. Conversely, a second report (28)
finds Tiam1-catalyzed exchange on Rac1 robustly activated
(5–6-fold) by PtdIns(4,5)P2 or PtdIns(4)P interacting through
the C-terminal PH domain. To address these discrepancies, we
demonstrated that similar to the DH/PH and PDZ/DH/PH ele-
ments of Tiam1, the identical Tiam1 construct (28) used in
previous studies (Tiam1-PH/PDZ/DH/PH) effectively catalyzes
release of GDP on Rac1 under a variety of experimental condi-
tions yet is not modulated by phosphoinositides.
There are several experimental aspects that must be consid-
ered when attempting to measure guanine nucleotide exchange
potentially modified by phosphoinositides. For instance, gua-
nine nucleotide exchange is traditionally evaluated using fil-
tration-based assays requiring separation of bound versus free
nucleotides, and previous relevant reports have used solid-
phase separation techniques to monitor exchange at single,
arbitrary time points (24, 25, 27, 28). Unfortunately, physical
separation of solution components introduces the potential to
perturb equilibrium conditions (50, 51). In contrast, the studies
described here rely upon the continuous, real time analysis of
exchange activity using fluorescence spectroscopy and do not
require altering the solution conditions in order to measure
exchange. Furthermore, small amounts of contaminating or-
ganic solvents normally required to solubilize phosphoinosi-
tides can dramatically affect guanine nucleotide exchange, pre-
sumably by destabilizing GEFs (see Fig. 5B). Reduced ex-
change activity would then be attributed inappropriately to the
added phosphoinositides as opposed to the vehicle solvent.
Nevertheless, the invariant association of DH domains with
C-terminal PH domains strongly suggests a strictly conserved
functional requirement that requires a reasonable explanation.
Previously determined crystal structures of PH domains bound
to inositol phosphates reveal that conformational alterations
induced upon complex formation are localized strictly to the
1/2 and 3/4 loops of the PH domains (21, 47, 48). In the
recent crystal structure of a DH/PH fragment of Tiam1 bound
to nucleotide-depleted Rac1 (15), the PH domain fails to engage
any part of Rac1, and it is difficult to imagine how phospho-
inositide binding to the PH domain allosterically influences DH
domain-mediated exchange in the absence of a membrane sur-
face. However, the physical nature of a two-dimensional sur-
face may introduce steric constraints on the ability of DH
domains linked to PH domains to engage membrane-resident
GTPases. The structural consequences of these membrane-
induced steric constraints may mediate a conserved functional
linkage between DH and PH domains. For example, the struc-
tures of the DH/PH element of Sos1 (52) as well as the complex
of Tiam1-DH/PH bound to Rac1 (15) and Dbs-DH/PH bound to
Cdc423 indicate a large degree of conformational heterogeneity
arising within the loops of the PH domain as wells as between
the PH domains with respect to the DH domains. It seems
plausible that the simultaneous engagement of GTPases and
phosphoinositides by the DH and PH domains, respectively,
may serve not only to regulate the intracellular localization of
the GEFs but may also dictate (a) the proper orientation of the
PH domains relative to the DH domains and (b) specific loop
conformations within PH domains that affect regulation of
exchange activity by as yet unclear molecular mechanisms.
Undoubtedly, it seems clear that future experiments using
prenylated G proteins resident in lipid vesicles and containing
specific phosphoinositides will be necessary to dissect the mo-
lecular and functional details dictating the invariant conserva-
tion of PH domains adjacent to DH domains.
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